Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PIRFENIDONE vs PITAVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PIRFENIDONE vs PITAVASTATIN: Safety Overview

Metric PIRFENIDONE PITAVASTATIN
Total FAERS Reports 37,933 2,344
Deaths Reported 8,895 346
Death Rate 23.4% 14.8%
Hospitalizations 7,004 351
Average Patient Age 73.7 yrs 65.1 yrs
% Female Patients 37.8% 56.0%
FDA Approval Date Apr 28, 2022 Apr 30, 2024
Manufacturer ScieGen Pharmaceuticals, Inc. Aurobindo Pharma Limited
Route ORAL ORAL
Marketing Status Prescription Prescription